Abstract
H1N1 swine influenza A virus (H1N1 SwIV) is one key subtype of influenza viruses with pandemic potential. MicroRNAs (miRNAs) are endogenous small RNA molecules that regulate gene expression. MiRNAs relevant with H1N1 SwIV have rarely been reported. To understand the biological functions of miRNAs during H1N1 SwIV infection, this study profiled differentially expressed (DE) miRNAs in pulmonary alveolar macrophages from piglets during the H1N1 SwIV infection using a deep sequencing approach, which was validated by quantitative real-time PCR. Compared to control group, 70 and 16 DE miRNAs were respectively identified on post-infection day (PID) 4 and PID 7. 56 DE miRNAs were identified between PID 4 and PID 7. Our results suggest that most host miRNAs are down-regulated to defend the H1N1 SwIV infection during the acute phase of swine influenza whereas their expression levels gradually return to normal during the recovery phase to avoid the occurrence of too severe porcine lung damage. In addition, targets of DE miRNAs were also obtained, for which bioinformatics analyses were performed. Our results would be useful for investigating the functions and regulatory mechanisms of miRNAs in human influenza because pig serves as an excellent animal model to study the pathogenesis of human influenza.
Similar content being viewed by others
Introduction
Influenza viruses are enveloped, negative-strand RNA viruses that are transmitted through contact with infected individuals or contaminated items and through inhalation of aerosols, leading to seasonal outbreaks of acute respiratory tract infection. Although yearly vaccination can provide some measure of protection, rapid mutation can yield emerging variants of influenza with the potential to cause pandemic infections1,2.
H1N1 swine influenza A virus (H1N1 SwIV) is one key subtype of influenza viruses, which circulates in pigs worldwide causing swine influenza characterized by fever, anorexia, tachypnea, dyspnea and coughing3,4. In March 2009, a novel swine-origin H1N1 influenza A virus containing gene segments from swine, human and avian influenza viruses circulated in humans and raised severe concerns about pandemic developments5, which indicates the significant role of H1N1-subtype influenza A virus in the evolution of new viruses with pandemic potential6.
Swine influenza has the characteristics of lasting for a short period and quick recovery. Lung is the major target organ for H1N1 SwIV infection because its replication is mainly restricted to epithelial cells in the respiratory tract7. However, there is no report whether pulmonary alveolar macrophages (PAMs) can be infected by H1N1 SwIV. As a short-lasting disease, swine influenza manifests itself with an incubation period of 1-3 days, then the recovery phase follows, which is limited to 6 or 7 days after infection8. This suggests that a large number of anti-viral molecules may play a central role in the infection course, which has been partly proved by previous studies. During the acute phase of the disease, H1N1 SwIV induces an overwhelming and simultaneous pro-inflammatory cytokines in the lungs of infected pigs such as Th1, Th2, Th3, IFN-alpha, tumor necrosis factor-alpha, interleukins and so on5,9,10. Among these cytokines, several have been demonstrated to be related with anti-viral functions or tissue damage at the acute stage of SwIV infection.
MicroRNAs (miRNAs) are endogenous, non-coding 21- to 23-nucleotide small RNA molecules that regulate gene expression by binding to the untranslated region of target mRNAs, leading to their translational inhibition or degradation11. Many studies have indicated miRNAs are attractive candidates as upstream regulators, because miRNAs can post-transcriptionally regulate the entire set of genes12. It is well known that many miRNAs are expressed after a specific virus infection or at a specific developmental stage. Moreover, in the analysis of the gene regulatory mechanisms, attention has been given to key factors in the clinical course and pathology of the disease, particularly when the host is infected with zoonosis, like SwIV. Therefore, identifying specific miRNAs is the first step to understand the biological functions of miRNAs during H1N1 SwIV infection.
The clinical manifestations and pathogenesis of influenza in pigs closely resemble those observed in humans5. Like humans, pigs are also outbred species and they are physiologically, anatomically and immunologically similar to humans13,14. In contrast to the mouse lung, the porcine lung has marked similarities to its human counterpart in terms of its tracheobronchial tree structure, lung physiology, airway morphology, abundance of airway submucosal glands and patterns of glycoprotein synthesis15,16,17. Furthermore, the cytokine responses in bronchoalveolar lavage fluid from SwIV-infected piglets are also identical to those observed for nasal lavage fluids of experimentally infected humans18. Recently, several studies have taken porcine genes such as BCL-G19, p58IPK20 and JAB121 as molecular models to study human diseases. These reports indicate that the pig can serve as an excellent animal model to study the pathogenesis of human influenza.
As mentioned above, many proteins, especially some cytokines, were found to be related to H1N1 SwIV. However, miRNAs related to H1N1 SwIV have rarely been reported. To obtain sufficient information on host response to H1N1 SwIV infection, the present study focused on differentially expressed (DE) miRNAs in pulmonary alveolar macrophages (PAMs) from piglets during the H1N1 SwIV infection. The comparison of H1N1 SwIV-infected and control PAMs indicated that 70 and 16 known miRNAs were differentially expressed respectively on post-infection day (PID) 4 and PID 7. The comparison of H1N1 SwIV-infected PAMs between PID 4 and PID 7 indicated that 56 known miRNAs were differentially expressed. As a result, these data would enable us to better understand the underlying pathogenesis of H1N1 SwIV infection in piglets.
Methods
Ethics Statement
Our study had been approved by Animal Care and Use Committee of Shaanxi Province, China. All animal procedures were performed according to guidelines developed by the China Council on Animal Care and protocol approved by Animal Care and Use Committee of Shaanxi Province, China.
Piglets and virus infection
A litter of six conventionally-reared, healthy 6-week-old, Yorkshire piglets was selected from a high-health commercial farm that has historically been free of all major pig diseases, such as H1N1, PRRSV, porcine circovirus type 2, classical swine fever virus, porcine parvovirus, pseudorabies virus, swine influenza virus and mycoplasma hyopneumoniae infections. All piglets were H1N1-seronegative determined by ELISA (HerdChek PRRS 2XR; IDEXX Laboratories) and absence of H1N1 tested by RT-PCR. Piglets were randomly assigned to three groups in the experiment and raised in isolated rooms. Four piglets were respectively inoculated with 105 TCID50/ml H1N1 (A/Swine/Guangdong/LM/2004(H1N1))22 by tracheal injection (3 ml). Two uninfected negative control piglets were treated similarly with an identical volume of PBS. H1N1 SwIV-infected piglets were clinically examined daily and rectal body temperatures were recorded from PID 1 to 7. Viral reisolates were performed after these piglets were killed. The infected group showed positive while the control group was negative.
Histopathological analysis
Two control piglets were euthanized on PID 0. Two infected piglets randomly chosen were euthanized on PID 4 and the rest two piglets were euthanized on PID 7. All piglets were euthanized by exsanguinations after intravenous administration of pentobarbital. Lung tissues from piglets in three groups were collected and the macroscopic lesions were estimated visually. Then, Lung tissues were fixed in 10% (w/v) buffered formaldehyde for 36 h and embedded in paraffin according to standard laboratory procedures. Serial sections were cut 5 μm thick from each of the formalin-fixed, paraffin-embedded tissues and were processed for hematoxylin-eosin (HE)-staining according to standard protocols.
RNA isolation and small RNA library construction
PAM samples were respectively collected from two control piglets on PID 0, two piglets on PID 4 and two piglets on PID 7 using lung lavage technique as previously described23. These PAM samples were observed by light microscopy to determine the purity in approximately 95% and then were immediately frozen in liquid nitrogen for RNA isolation.
Total RNA from PAM samples was extracted using the mirVana™ miRNA Isolation Kit (Ambion, Austin, TX) according to the manufacturer's instructions. RNA samples from two piglets on PID 0, PID 4 or PID 7 were respectively mixed as sample on PID 0, PID 4 or PID 7. The RNA quality of three samples was assessed using a BioAnalyzer 2100 (Agilent Technology, Santa Clara, CA). The purified RNA was quantified by determining the absorbance at 260 nm using a Nanodrop ND-1000 spectrophotometer (Infinigen Biotechnology Inc., City of Industry, CA). RT-PCR was used to determine the infection of H1N1 SwIV in PAM samples on PID 4 and PID 7. Exactly, PB2 gene was amplified with the following primer pair: forward, 5′-AATTACAACAAAGGCACCA-3′ and reverse, 5′-GCTTCCGTTTCATTACCA-3′. RNA samples were sequenced with Solexa/Illumina platform by BGI (Beijing Genome Institute at Shenzhen, China).
For small RNA library construction and deep sequencing, the 18–30 nt size range of RNA was enriched by polyacrylamide gel electrophoresis and then 20 µg of the purified small RNA from each sample was subject to DNA sequencing with an Illumina Genome Analyzer (Illumina, San Diego, CA) according to the manufacturer's instructions. In brief, proprietary adapters were then ligated to the 5′ and 3′ termini of these small RNAs, of which the ligated small RNAs were then used as templates for cDNA synthesis. The cDNA was amplified with 18 PCR cycles to produce libraries that were sequenced using Solexa's proprietary sequencing-by-synthesis method. The image files generated by the sequencer were then processed to produce digital-quality data. After masking of adaptor sequences and removal of contaminated reads, we got the clean reads of full-length small RNA sequences for further analysis. To confirm the quality of these sequencing data, we calculated the average quality score of sites and reads of each sample.
Search for known miRNAs expressed in each sample
To identify known porcine miRNAs (known miRNAs refer to miRNAs that have been included in miRBase) expressed in each sample, the miRBase version 19.0 containing 306 mature porcine miRNAs (http://www.mirbase.org/) was downloaded and a BLASTN search was performed to align the unique sequence reads with porcine precursor miRNA sequences. The hits were considered a real match if there were a minimum of 18 nucleotides matched between the sequence read and the miRNA from the database.
Identification and analysis of DE miRNAs
To identify the DE miRNAs between samples, the count of one known miRNA in each sample was normalized against the total counts of all known miRNAs in this sample. The normalization formula is described as follows: Normalized expression level = the count of one known miRNA/total counts of all known miRNAs × 106. Then, the fold change of one miRNA between samples was calculated and the following formula was used: Fold change = log 2 (treatment/control). Statistical analysis was performed and significance values were determined as previously described24. A p-value below 0.01 was considered as significant. Scatter plots were created to visually demonstrate the changing trends of known miRNA expression levels. Published references were searched to identify DE miRNAs that were conservative between pig and humans during the infection with H1N1 influenza A virus.
MiRNA expression pattern clustering was performed using miRNAs with significant expression variance. All DE miRNAs were clustered using the hierarchical cluster (Version 3.0) software and the results were visualized using the TreeView (Version 1.1.1) software.
Quantitative real-time PCR (qRT-PCR) experiments
To validate the sequencing results, qRT-PCR experiments were conducted for 5 randomly selected miRNAs using the All-in-OneTM miRNA qRT-PCR detection system (GeneCopoeia, Rockville, USA). Briefly, total RNAs from three groups were prepared as mentioned above. Then, 100 ng of total RNA was used to conduct reverse transcription of miRNAs with the All-in-OneTM miRNA First-Strand cDNA synthesis kit (GeneCopoeia, Rockville, USA) as per the manufacturer's instructions. 2 μl of first-strand cDNA (diluted at 1:5) was used to conduct the qRT-PCR with the miRNA-specific forward primers and the universal adaptor PCR primer (provided by the qPCR kit) using the All-in-OneTM miRNA qPCR Kit as per the manufacturer's instructions. All reactions were run in triplicate and porcine U6 snRNA was used as an endogenous reference. The ΔΔCt method was used to calculate the expression level differences of miRNAs between examined samples. The miRNA-specific forward primers and U6 snRNA primers were listed in Table S1.
Identification of transcription factors (TFs) relevant with DE miRNAs
To identify TFs which regulate the expression of DE miRNAs, the data of interactions between TFs and miRNAs were downloaded from TransmiR database (http://202.38.126.151/hmdd/mirna/tf/). Then, DE miRNAs were aligned with these data to find the relevant TFs.
Targets prediction for DE miRNAs
To predict targets of DE miRNAs, our strategy included three parts. For DE miRNAs whose sequences are absolutely consistent with that of human miRNAs with targets verified by experiments, targets of human miRNAs were downloaded from miRecords (http://mirecords.biolead.org/), miRTarBas (http://mirtarbase.mbc.nctu.edu.tw/index.html), or TarBase (http://diana.cslab.ece.ntua.gr/tarbase/) as targets of homologs in piglet. For DE miRNAs whose sequences are absolutely consistent with human miRNAs without targets verified by experiments, predicted targets of human miRNAs were downloaded from DIANA-MICROT (http://diana.pcbi.upenn.edu/cgi-bin/micro_t.cgi), MIRDB (http://www.mirdb.org/), or TargetScan (http://www.targetscan.org/) as targets of homologs in pig. For DE miRNAs whose sequences are different from that of human miRNAs, targets were predicted based on 3′UTR sequences of pig genome and sequences of pig miRNAs using software miRanda, PITA, or RNAhybird, respectively. Then, the intersected targets from these three softwares were used as the predicted targets.
Functional annotation analyses of DE miRNA targets
To fully investigate the functions of the DE miRNA targets, we performed Gene Ontology (GO) enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses for the predicted miRNA targets using the david gene annotation tool (http://david.abcc.ncifcrf.gov/). Hypergeometric test and Benjamini & Hochberg false discovery rate were performed using the default parameters to adjust the p-value (p<0.05).
Construction of protein-protein interaction (PPI) network regulated by DE miRNAs
Firstly, 33718 porcine protein sequences were downloaded from Uniprot database and saved as FASTA format. According to target genes encoding proteins and the same accession number for one protein in different databases, information of proteins regulated by DE miRNAs was obtained by mapping the predicted target genes to proteins. Then, target proteins were mapped to porcine PPI network containing 567586 pairs of PPI constructed by Wang et al.25. The PPI network regulated by DE miRNAs was visualized using the Cytoscape software, in which bigger degrees were shown in a larger font.
The data discussed in this publication have been deposited in NCBI's Gene Expression Omnibus database (http://www.ncbi.nlm.nih.gov/geo/) under the accession number GSE49249.
Results
The pulmonary pathological changes of piglets infected by H1N1 SwIV
By monitoring clinical signs of all piglets, it was found that piglets in infected groups showed mild signs, such as coughing, dyspnea and shivering on PID 2-4 and recovered on PID 5-7. The average body temperature of infected piglets started to increase on PID 2, rose to 40.9°C on PID 3 and returned to the initial temperature (about 39°C) until PID 6. As expected, piglets in the control group showed no clinical signs and the body temperature had also no changes. Lung tissues in each group were collected and the macroscopic lesions of lungs tissues were estimated visually (Fig. 1A and B). The pulmonary pathological injury was analyzed using HE-staining. As shown in Fig. 1C, lung tissues from piglets in control group (PID 0) showed a normal structure and no histopathological changes under a light microscope. In infected groups (PID 4 and PID 7), lung tissues indicated widespread alveolar wall thickness caused by alveolar wall capillary congestion, bronchial and alveolar cavity serofluid exudation, mild proliferation of fibroblasts in pulmonary lobule and bronchial mucosal desquamation. Additionally, the infection of H1N1 SwIV in PAM samples on PID 4 and PID 7 was also determined by RT-PCR. As shown in Fig. 1D, both PAM samples from each group had equivalent amounts of infection.
Construction of three different small RNA libraries by Solexa sequencing
In order to identify DE miRNAs in porcine PAMs at different time points post infection with H1N1 SwIV, three different small RNA libraries were sequenced using Solexa technology. After removing the reads of low quality and masking adaptor sequences, total reads of 18 to 30 nucleotides in length were obtained from three samples. From the size distribution of total reads, we found the length distribution peaked at 21 to 23 nucleotides and more than half of these clean reads (78.97%, 53.78% and 80.51% on PID 0, 4, 7, respectively) were 21 to 23 nucleotides in length, consistent with the common size of miRNA (Fig. 2).
Category analysis of DE miRNAs
Based on criteria mentioned above in materials and methods section, known porcine miRNAs in each sample were identified. The numbers of known miRNAs were listed in Table 1. The frequency of individual miRNAs in one sample can be used to compare the relative expression of miRNAs between samples26. Thus, we tested the differential expression of miRNAs in samples of PID 4 and PID 7 based on the normalized reads according to the criteria of |fold change| ≥ 1.5 and p < 0.01. The positive value of fold change means the up-regulation of one miRNA while the negative value means the down-regulation of one miRNA. In total, compared with PID 0, 70 known porcine miRNAs were differentially expressed in the sample of PID 4, 8 of which were up-regulated while 62 were down-regulated; 16 known porcine miRNAs were differentially expressed in the sample of PID 7, 6 of which were up-regulated while 10 were down-regulated. 56 known porcine miRNAs were differentially expressed in the sample of PID 7 compared with PID 4, 49 of which were up-regulated while 7 were down-regulated. The changing trends of miRNA expression level were demonstrated by scatter plots (Fig. 3) and details of DE miRNAs were listed in Table S2, S3 and S4. We then conducted the clustering for DE miRNAs in each sample by hierarchical cluster and the results were shown by heat map (Fig. 4). As shown in the heat map, compared with sample on PID 0, most miRNAs were down-regulated in sample on PID 4, whereas only few miRNAs were differentially expressed in sample on PID 7. Compared with sample on PID 4, a majority of miRNAs were up-regulated in sample on PID 7.
Validation of DE miRNAs by qRT-PCR
To validate the Solexa sequencing results, qRT-PCR was performed separately to investigate the relative expression levels of 5 randomly selected DE miRNAs (ssc-miR-424-3p, ssc-miR-542-5p, ssc-miR-365-5p, ssc-miR-450b-5p, ssc-miR-450a). As shown in Fig. 5, compared with PID 0, the selected miRNAs were down-regulated on PID 4. Compared with PID 4, these miRNAs were up-regulated on PID 7. In general, the changing trends of these miRNAs in the qRT-PCR results were similar to those in the Solexa sequencing results. Therefore, the qRT-PCR results validated the Solexa sequencing results.
To confirm the possibility of using pig as a model to study human influenza, we searched publications to identify DE miRNAs that were conservative between swine and humans after the H1N1 influenza A virus infection. Interestingly, many DE miRNAs, such as miR-542-3p, miR-30d, miR-30c, miR-23a, miR-125b and so on27,28,29,30, were found conservative (Table 2).
TFs relevant with DE miRNAs
The interactions of miRNAs with TFs were downloaded from TransmiR database, in which TFs regulating DE miRNAs were identified. On PID 4, partial DE miRNAs were regulated by TFs, such as AKT1, AKT2, AKT3, E2F1, EGR1, ERS1, STAT3, MAPK14, MYC, TGFB1, TLX1, TLX3, NFKB1 and TP53 (Fig. 6A). On PID 7, partial DE miRNAs were regulated by TFs, such as EGR1, BRCA1, CEBPA, YY1, MYF5, MRF4, SLUG and MEF2C (Fig. 6B). Compared with PID 4, partial DE miRNAs on PID 7 were regulated by TFs, such as AKT1, E2F1, EGR1, ERS1, MYC, TGFB1, TP53, etc. (Fig. 6C). As shown in Fig. 7, by analysis of GO function annotation, these TFs mainly participate in biological processes including host defense response, inflammatory immune response, apoptosis, metabolism, growth and transcription, etc.
MiRNA target prediction and functional annotation analyses
According to the strategy described in materials and methods section, predicted targets of DE miRNAs were obtained. As a result, 1472 targets were predicted for the 70 DE miRNAs between sample on PID 4 and PID 0 (Fig. 6A); 304 targets were predicted for the 16 DE miRNAs between sample on PID 7 and PID 0 (Fig. 6B); 1217 targets were predicted for the 56 DE miRNAs between sample on PID 7 and PID 4 (Fig. 6C). As expected, most miRNAs targeted hundreds of genes and vice versa. These targets were sorted by the enrichment of GO categories based on the DAVID databases and mainly clustered into different functional groups (Fig. 7). These targets were also analyzed by KEGG pathway annotation. The key pathways, in which DE miRNA targets were involved, were respectively obtained (Table 3, 4 and 5). Among these key pathways, MAPK, focal adhesion, p53 and B cell receptor signaling pathways were closely related to immune and inflammatory responses. Therefore, we analyzed these pathways in detail (Fig. S1, S2, S3 and S4).
PPI networks regulated by DE miRNAs
The PPI networks regulated by DE miRNAs after infection with H1N1 SwIV at different time points were constructed as described in materials and methods section. Then, the degree distribution analysis was performed, according to which PPI networks containing proteins with the top 10 highest degrees were extracted. As shown in Fig. 8A, in the PPI network mediated by DE miRNAs on PID 4, 10 node proteins were A7XNS1 (Nuclear factor of kappa light polypeptide enhancer in B-cells 1 encoded by gene NFKB1), A3RGC1 (Vitamin D3 receptor encoded by gene VDR), A5A753 (Epidermal growth factor receptor encoded by gene EGFR), P49151 (Vascular endothelial growth factor A encoded by gene VEGFA), A5GFM7 (Natural cytotoxicity triggering receptor 1 encoded by gene NCR1), F1RZU8 (uncharacterized protein encoded by gene DST), F1SV22 (uncharacterized protein encoded by gene MACF1), F1SHY0 (uncharacterized protein encoded by gene SOS2), F1RSM3 (uncharacterized protein encoded by gene HELZ) and F1RW14 (uncharacterized protein encoded by gene WDFY3). Similarly, as shown in Fig. 8B, in the PPI network mediated by DE miRNAs on PID 7, 10 node proteins were A7XNS1, F1RHA7 (Transforming growth factor-beta-induced protein ig-h3 encoded by gene TGFBI), Q8WMZ2 (CD80 encoded by gene CD80), Q00655 (Tyrosine-protein kinase SYK encoded by gene SYK), C7C1K5 (SMAD family member 2 encoded by gene SMAD2), C9DRN2 (Suppressor of cytokine signaling 1 encoded by gene SOCS1), F1RZU8, F1RSE7 (uncharacterized protein encoded by gene MCM4), F1S4P6 (Eukaryotic translation initiation factor 3 subunit A encoded by gene EIF3A) and F1RRA2 (uncharacterized protein encoded by gene SPRY1). As shown in Fig. 8C, in the PPI network mediated by DE miRNAs between PID 4 and PID 7, 10 node proteins were A3RGC1, A5A753, P49151, F1RZU8, F1SV22, F1SIW0 (uncharacterized protein encoded by gene STAB1), F1RSM3, F1RW14, F1RSE7 and F1SKW1 (uncharacterized protein encoded by gene RC3H2).
Discussion
Recently, the impact of miRNAs expression on understanding molecular mechanisms in gene regulations has been remarkable because a single miRNA has the potential to target hundreds of distinct mRNA molecules and one mRNA molecule can be regulated by multiple miRNAs31, which means that miRNAs are attractive candidates as regulators of multiple pathways. However, it has become gradually clear that not all miRNAs are equally significant. Specific miRNAs emerge as principal regulators that control major cell functions in various physiological and pathological settings32. Therefore, the search for master miRNAs and related target genes in response to H1N1 SwIV infection and underlying molecular mechanisms is consecutively one of the most important areas in H1N1 SwIV research.
In the present study, we have mainly investigated DE miRNAs in PAMs from piglets at different time points post infection with H1N1 SwIV compared with control piglets. To our knowledge, this is the first study to profile DE miRNAs in H1N1 SwIV infected piglets by Solexa deep sequencing approach. The integration of Solexa deep sequencing technology, DE miRNA analysis, target prediction, functional annotation analyses of targets and PPI network construction has allowed us to perform a robust comparative genomics and bioinformatics study to reveal the host miRNA molecular signatures associated with H1N1 SwIV infection. Our results also revealed the cellular pathways and PPI networks associated with the differentially expressed host miRNAs during the H1N1 SwIV life cycles. We identified a unique series of cellular miRNAs, providing, for the first time, key molecular insights into unique cellular miRNA-target interactome networks dynamically and temporarily affected by H1N1 SwIV infection.
As shown in Fig. 3A (see also Table S2), compared with PID 0, there are 70 DE miRNAs on PID 4, although most of which are down-regulated, a few are up-regulated; On PID 7, the number of DE miRNAs decreased substantially and there were only 16 DE miRNAs (Fig. 3B; see also Table S3). In addition, compared with PID 4, there are 56 DE miRNAs on PID 7 and a majority of them were up-regulated (Fig. 3C; see also Table S4). Taken together, these results suggest that a large number of miRNAs are down-regulated resulting in the up-regulation of their targets to defend the virus infection during the acute phase (on PID 4). Then, during the recovery phase (on PID 7), expression levels of these down-regulated miRNAs return to normal, leading to the normal expression of immune regulators. However, these results need to be confirmed in the subsequent experiments.
Among these DE miRNAs, consistent with previous studies, many of themselves or their homologs were reported to be closely related with influenza virus infection. For instance, gga-miR-18, gga-miR-193a, gga-miR-193b, gga-miR-30b, miR-1c, gga-miR-146a, gga-miR-24, gga-miR-92, gga-miR-1306, gga-miR-7b, gga-miR-7-1 and gga-miR-7-2 were differentially expressed in chicken lungs infected with avian influenza virus33; miR-574-3p, miR-574-5p, miR-744*, miR-30a, miR-30d, miR-205, miR-532-3p and let-7g were differentially expressed in A549 cells infected with swine-origin H1N1 or avian-origin H7N7 influenza A virus29; let-7e, let-7f, miR-193, miR-27a, miR-27b, miR-30a and miR-30d were differentially expressed in mice infected with recombinant influenza A H1N1 virus strains r1918 or Tx/9134; miR-1, miR-23a, miR-30b, miR-30c, miR-30d and miR-99b were differentially expressed in cynomolgus macaques infected with highly pathogenic H5N1 avian virus35; gga-miR-1a-1, gga-miR-1a-2, gga-miR-99a, gga-let-7c, gga-miR-30d, gga-miR-125b, gga-miR-1b, gga-miR-146b, gga-miR-27b, gga-miR-22, gga-miR-30a-3p, gga-miR-30a-5p, gga-miR-30c-1, gga-miR-24, gga-miR-30c-2, gga-miR-1b and gga-miR-9 were differentially expressed in chicken lung and trachea infected with avian influenza virus36.
However, there are still some differences between our results and previous studies. Firstly, some down-regulated miRNAs were reported to be up-regulated in previous studies. For example, gga-miR-18, gga-miR-193a, gga-miR-193b, gga-miR-30b, gga-miR-146a, gga-miR-24, gga-miR-92, gga-miR-7b, gga-miR-7-1 and gga-miR-7-2 are up-regulated after avian influenza virus infection in previous studies whereas in our results these miRNAs are down-regulated on PID 433. In addition, expression patterns of miR-574-3p, miR-574-5p, miR-744*, miR-30a, miR-30d, miR-205 and miR-532-3p are also inconsistent with our results29. We speculate that these differences attribute to the different viruses, animals, analysis methods and even the different host regulatory mechanisms response to virus infection. Secondly, we also identified many interesting DE miRNAs that had not been linked to influenza virus infection but other diseases in previous studies. For example, miR-365, miR-503, miR-326, miR-149, miR-185, miR-191 and miR-425 were reported to play important roles in regulating kinds of tumorigenesis such as lung cancer, endometrioid endometrial cancer, brain tumor, colorectal cancer, prostate cancer, breast cancer and so on37,38,39,40,41,42,43. Recently, a study reported that infections with viruses, bacteria and parasites could contribute to tumorigenesis44. Taken together, our results suggest that influenza virus infection may be related to tumorigenesis to some extent. However, this conjecture needs to be explored in the future study.
TFs, an important class of gene regulators, can regulate the expression of miRNAs or be regulated by miRNAs45,46,47. In our study, as shown in Fig. 6, DE miRNAs were regulated by several TFs during H1N1 SwIV infection and vice versa. Furthermore, these TFs were closely related to immune defense (Fig. 7). These results will be helpful to study the roles of the interactions of TFs with miRNAs during H1N1 SwIV infection.
As indicated by previous reports, pig can serve as an excellent animal model to study the pathogenesis of human influenza, which was preliminarily confirmed by our results. As shown in Table 2, many DE miRNAs were identified conservative between pig and humans during the H1N1 influenza A virus infection27,28,29,30. This result indicates that in the future study we can use pig as a model to study human influenza, especially these conservative DE miRNAs.
Many studies indicate that inflammatory responses might result in influenza-induced pathogenesis5,10,48. Specially, H1N2 influenza virus was reported to cause pathological damage to lungs due to its induction of pro-inflammatory cytokines such as IL-1, IL-8 and TNF-α10. Interestingly, on both PID 4 and PID 7, there are several up-regulated DE miRNAs whose targets are genes encoding immune and inflammatory cytokines (Table S5, S6, S7 and S8), base on which we can speculate that these up-regulated DE miRNAs serve as negative regulators for immune and inflammatory cytokines during H1N1 SwIV infection to avoid too severe porcine lung damage.
As shown in Table 3, 4 and 5, by KEGG pathway annotation, DE miRNAs at different time points were found to be involved in many key pathways such as MAPK signaling pathway, focal adhesion, cytokine-cytokine receptor interaction, Jak-STAT signaling pathway, chemokine signaling pathway, T cell receptor signaling pathway and so on, most of which were reported to be related with the influenza virus infection49.
Take MAPK signaling pathway for instance, as shown in Fig. S1A, on PID 4, there are 38 DE miRNAs involved in MAPK signaling pathway and most DE miRNAs such as miR-450b-5p, miR-146b, miR-1343, miR-128 and miR-30a-5p were down-regulated while their targets such as MEF2C, NFKB1, TGFBR1, EGFR, JUN and MAPK1 are key factors in MAPK signaling pathway (see map 04010 in KEGG database). As a result, on PID 4, MAPK signaling pathway was activated. As shown in Fig. S1B, the number of DE miRNAs involved in MAPK signaling pathway significantly decreased on PID 7, which suggests that abnormal cell proliferation, differentiation and apoptosis were reduced. Compared with PID 4, most of DE miRNAs involved in MAPK signaling pathway were up-regulated on PID 7 (Fig. S1C), which means MAPK signaling pathway was inhibited. Other signaling pathways also appear similar situations. Taken together, it is therefore intriguing to speculate that during the acute phase of H1N1 SwIV infection, the host turns on many signaling pathways mentioned above to defend the virus infection; however, during the recovery phase, most of signaling pathways are turned off to avoid too severe tissue damage.
Biological processes inside cells are governed by the well-organized protein-protein interaction networks, which act as molecular machines performing different functionality. One key aim of post-genomic biology is to reconstruct the complete molecular interaction networks within cells and on the basis of which to understand the principles on the construction, function and evolution of life. In this study, we constructed the PPI networks regulated by DE miRNAs after infection with H1N1 SwIV at different time points. According to degree distribution analysis, three sub-networks containing proteins with the top 10 highest degrees were extracted. As shown in Fig. 8, most of these node proteins are related to virus infection such as Nuclear factor of kappa light polypeptide enhancer in B-cells 1, Natural cytotoxicity triggering receptor 1, Suppressor of cytokine signaling 1, Epidermal growth factor receptor, Vitamin D3 receptor, CD80, Tyrosine-protein kinase SYK and SMAD family member 250,51,52,53,54,55,56,57,58. Therefore, as the node proteins in PPI networks regulated by DE miRNAs, these proteins may be closely related with H1N1 SwIV infection. Furthermore, the PPI networks may provide useful information to study the interaction between host and H1N1 SwIV virus.
In this study we presented the profile of DE miRNAs in porcine PAMs during the H1N1 SwIV virus infection for the first time to our knowledge. Our results suggest that most host miRNAs are down-regulated to defend the infection of H1N1 SwIV during the acute phase of swine influenza whereas their expression levels gradually return to normal during the recovery phase to avoid the occurrence of too severe porcine lung damage. Furthermore, we also obtained targets of DE miRNAs, performed GO and KEGG analyses for these targets and constructed PPI networks regulated by DE miRNAs. The identification and functional annotation analyses of these DE miRNAs will be very useful for further investigating the functions and regulatory mechanisms of miRNAs in piglets infected with influenza virus.
References
Cheng, V. C., To, K. K., Tse, H., Hung, I. F. & Yuen, K. Y. Two years after pandemic influenza A/2009/H1N1: what have we learned? Clin Microbiol Rev 25, 223–263, 10.1128/cmr.05012-11 (2012).
Kreijtz, J. H., Fouchier, R. A. & Rimmelzwaan, G. F. Immune responses to influenza virus infection. Virus Res 162, 19–30, 10.1016/j.virusres.2011.09.022 (2011).
Van Reeth, K., Nauwynck, H. & Pensaert, M. Clinical effects of experimental dual infections with porcine reproductive and respiratory syndrome virus followed by swine influenza virus in conventional and colostrum-deprived pigs. J Vet Med B Infect Dis Vet Public Health 48, 283–292 (2001).
Brown, I. H. et al. Antigenic and genetic analyses of H1N1 influenza A viruses from European pigs. J Gen Virol 78 (Pt 3), 553–562 (1997).
Khatri, M. et al. Swine influenza H1N1 virus induces acute inflammatory immune responses in pig lungs: a potential animal model for human H1N1 influenza virus. J Virol 84, 11210–11218, 10.1128/jvi.01211-10 (2010).
Dawood, F. S. et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360, 2605–2615, 10.1056/NEJMoa0903810 (2009).
Olsen, C. W. B. I., Easterday, B. C. & Van Reeth, K. Swine influenza. In Diseases of swine. 9 edition edn, 469–482 (Ames: Iowa State University Press, 2006).
Loving, C. L. et al. Influenza virus coinfection with Bordetella bronchiseptica enhances bacterial colonization and host responses exacerbating pulmonary lesions. Microb Pathog 49, 237–245, 10.1016/j.micpath.2010.06.004 (2010).
Barbe, F., Atanasova, K. & Van Reeth, K. Cytokines and acute phase proteins associated with acute swine influenza infection in pigs. Vet J 187, 48–53, 10.1016/j.tvjl.2009.12.012 (2011).
Jo, S. K., Kim, H. S., Cho, S. W. & Seo, S. H. Pathogenesis and inflammatory responses of swine H1N2 influenza viruses in pigs. Virus Res 129, 64–70, 10.1016/j.virusres.2007.05.005 (2007).
Carthew, R. W. & Sontheimer, E. J. Origins and Mechanisms of miRNAs and siRNAs. Cell 136, 642–655, 10.1016/j.cell.2009.01.035 (2009).
Friedman, R. C., Farh, K. K., Burge, C. B. & Bartel, D. P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19, 92–105, 10.1101/gr.082701.108 (2009).
Rogers, C. S. et al. Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs. Science 321, 1837–1841, 10.1126/science.1163600 (2008).
Rogers, C. S. et al. The porcine lung as a potential model for cystic fibrosis. Am J Physiol Lung Cell Mol Physiol 295, L240–263, 10.1152/ajplung.90203.2008 (2008).
Cunningham, S., Meng, Q. H., Klein, N., McAnulty, R. J. & Hart, S. L. Evaluation of a porcine model for pulmonary gene transfer using a novel synthetic vector. J Gene Med 4, 438–446, 10.1002/jgm.270 (2002).
Choi, H. K., Finkbeiner, W. E. & Widdicombe, J. H. A comparative study of mammalian tracheal mucous glands. J Anat 197 Pt 3, 361–372 (2000).
Goco, R. V., Kress, M. B. & Brantigan, O. C. Comparison of mucus glands in the tracheobronchial tree of man and animals. Ann N Y Acad Sci 106, 555–571 (1963).
Hayden, F. G. et al. Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J Clin Invest 101, 643–649, 10.1172/jci1355 (1998).
Jiang, P., Li, D., Bi, L. & Zhang, D. BCL-G as a new candidate gene for immune responses in pigs: bioinformatic analysis and functional characterization. Vet Immunol Immunopathol 150, 112–117, 10.1016/j.vetimm.2012.08.001 (2012).
Jiang, P. et al. Characterization of porcine P58IPK gene and its up-regulation after H1N1 or H3N2 influenza virus infection. J Clin Virol 58, 120–126, 10.1016/j.jcv.2013.06.007 (2013).
Jiang, P., Wang, J., Kang, Z., Li, D. & Zhang, D. Porcine JAB1 significantly enhances apoptosis induced by staurosporine. Cell Death Dis 4, e823, 10.1038/cddis.2013.357 (2013).
Liu, D. F., Liu, M., Liu, C. G., Yang, T. & Liu, D. C. [Cloning and phylogenetic analysis of the entire gene of an H1N1 subtype swine influenza virus isolated from Guangdong Province]. Bing Du Xue Bao 24, 358–363 (2008).
Zhang, H. et al. Changes in the cellular proteins of pulmonary alveolar macrophage infected with porcine reproductive and respiratory syndrome virus by proteomics analysis. J Proteome Res 8, 3091–3097, 10.1021/pr900002f (2009).
Audic, S. & Claverie, J. M. The significance of digital gene expression profiles. Genome Res 7, 986–995 (1997).
Wang, F. et al. Prediction and characterization of protein-protein interaction networks in swine. Proteome Sci 10, 2, 10.1186/1477-5956-10-2 (2012).
Bar, M. et al. MicroRNA discovery and profiling in human embryonic stem cells by deep sequencing of small RNA libraries. Stem Cells 26, 2496–2505, 10.1634/stemcells.2008-0356 (2008).
Tambyah, P. A. et al. microRNAs in circulation are altered in response to influenza A virus infection in humans. PLoS One 8, e76811, 10.1371/journal.pone.0076811 (2013).
Song, H. et al. Microarray analysis of microRNA expression in peripheral blood mononuclear cells of critically ill patients with influenza A (H1N1). BMC Infect Dis 13, 257, 10.1186/1471-2334-13-257 (2013).
Loveday, E. K., Svinti, V., Diederich, S., Pasick, J. & Jean, F. Temporal- and strain-specific host microRNA molecular signatures associated with swine-origin H1N1 and avian-origin H7N7 influenza A virus infection. J Virol 86, 6109–6122, 10.1128/jvi.06892-11 (2012).
Buggele, W. A., Johnson, K. E. & Horvath, C. M. Influenza A virus infection of human respiratory cells induces primary microRNA expression. J Biol Chem 287, 31027–31040, 10.1074/jbc.M112.387670 (2012).
Lewis, B. P., Burge, C. B. & Bartel, D. P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15–20, 10.1016/j.cell.2004.12.035 (2005).
Krichevsky, A. M. & Gabriely, G. miR-21: a small multi-faceted RNA. J Cell Mol Med 13, 39–53, 10.1111/j.1582-4934.2008.00556.x (2009).
Wang, Y. et al. Integrated analysis of microRNA expression and mRNA transcriptome in lungs of avian influenza virus infected broilers. BMC Genomics 13, 278, 10.1186/1471-2164-13-278 (2012).
Li, Y. et al. MicroRNA expression and virulence in pandemic influenza virus-infected mice. J Virol 84, 3023–3032, 10.1128/jvi.02203-09 (2010).
Li, Y. et al. Differential microRNA expression and virulence of avian, 1918 reassortant and reconstructed 1918 influenza A viruses. Virology 421, 105–113, 10.1016/j.virol.2011.09.011 (2011).
Wang, Y. et al. Identification of differentially expressed miRNAs in chicken lung and trachea with avian influenza virus infection by a deep sequencing approach. BMC Genomics 10, 512, 10.1186/1471-2164-10-512 (2009).
Xu, Y. Y. et al. MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1. FEBS J, 10.1111/febs.12365 (2013).
Qu, F. et al. MicroRNA-185 suppresses proliferation, invasion, migration and tumorigenicity of human prostate cancer cells through targeting androgen receptor. Mol Cell Biochem 377, 121–130, 10.1007/s11010-013-1576-z (2013).
Oster, B. et al. Non-CpG island promoter hypomethylation and miR-149 regulate the expression of SRPX2 in colorectal cancer. Int J Cancer 132, 2303–2315, 10.1002/ijc.27921 (2013).
Nagpal, N., Ahmad, H. M., Molparia, B. & Kulshreshtha, R. MicroRNA-191, an estrogen-responsive microRNA, functions as an oncogenic regulator in human breast cancer. Carcinogenesis, 10.1093/carcin/bgt107 (2013).
Kang, S. M., Lee, H. J. & Cho, J. Y. MicroRNA-365 regulates NKX2-1, a key mediator of lung cancer. Cancer Lett 335, 487–494, 10.1016/j.canlet.2013.03.006 (2013).
Di Leva, G. et al. Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status. PLoS Genet 9, e1003311, 10.1371/journal.pgen.1003311 (2013).
Kefas, B. et al. The neuronal microRNA miR-326 acts in a feedback loop with notch and has therapeutic potential against brain tumors. J Neurosci 29, 15161–15168, 10.1523/jneurosci.4966-09.2009 (2009).
de Martel, C. et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 13, 607–615, 10.1016/s1470-2045(12)70137-7 (2012).
Yamakuchi, M. & Lowenstein, C. J. MiR-34, SIRT1 and p53: the feedback loop. Cell Cycle 8, 712–715 (2009).
Mraz, M., Pospisilova, S., Malinova, K., Slapak, I. & Mayer, J. MicroRNAs in chronic lymphocytic leukemia pathogenesis and disease subtypes. Leuk Lymphoma 50, 506–509, 10.1080/10428190902763517 (2009).
Cui, Q., Yu, Z., Pan, Y., Purisima, E. O. & Wang, E. MicroRNAs preferentially target the genes with high transcriptional regulation complexity. Biochem Biophys Res Commun 352, 733–738, 10.1016/j.bbrc.2006.11.080 (2007).
Szretter, K. J. et al. Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J Virol 81, 2736–2744, 10.1128/jvi.02336-06 (2007).
Watanabe, T., Watanabe, S. & Kawaoka, Y. Cellular networks involved in the influenza virus life cycle. Cell Host Microbe 7, 427–439, 10.1016/j.chom.2010.05.008 (2010).
Wang, X. F. et al. PD-1/PDL1 and CD28/CD80 pathways modulate natural killer T cell function to inhibit hepatitis B virus replication. J Viral Hepat 20 Suppl 127–39, 10.1111/jvh.12061 (2013).
Shao, R. X. et al. SOCS1 abrogates IFN's antiviral effect on hepatitis C virus replication. Antiviral Res 97, 101–107, 10.1016/j.antiviral.2012.12.001 (2013).
Hatton, O. et al. Syk-induced phosphatidylinositol-3-kinase activation in Epstein-Barr virus posttransplant lymphoproliferative disorder. Am J Transplant 13, 883–890, 10.1111/ajt.12137 (2013).
Seidel, E., Glasner, A. & Mandelboim, O. Virus-mediated inhibition of natural cytotoxicity receptor recognition. Cell Mol Life Sci, 10.1007/s00018-012-1001-x (2012).
Salhan, D. et al. HIV-induced kidney cell injury: role of ROS-induced downregulated vitamin D receptor. Am J Physiol Renal Physiol 303, F503–514, 10.1152/ajprenal.00170.2012 (2012).
Glasner, A. et al. Elucidating the mechanisms of influenza virus recognition by Ncr1. PLoS One 7, e36837, 10.1371/journal.pone.0036837 (2012).
Xu, S., Xue, C., Li, J., Bi, Y. & Cao, Y. Marek's disease virus type 1 microRNA miR-M3 suppresses cisplatin-induced apoptosis by targeting Smad2 of the transforming growth factor beta signal pathway. J Virol 85, 276–285, 10.1128/jvi.01392-10 (2011).
Kung, C. P. & Raab-Traub, N. Epstein-Barr virus latent membrane protein 1 modulates distinctive NF- kappaB pathways through C-terminus-activating region 1 to regulate epidermal growth factor receptor expression. J Virol 84, 6605–6614, 10.1128/jvi.00344-10 (2010).
Droebner, K. et al. The alternative NF-kappaB signalling pathway is a prerequisite for an appropriate immune response against lymphocytic choriomeningitis virus infection. Viral Immunol 23, 295–308, 10.1089/vim.2009.0101 (2010).
Acknowledgements
This work was supported by the National Natural Science Foundation of China (Grant No. 31072115), the opening foundation of the State Key Laboratory of Biology Macromolecule of Institute of Biophysics, Chinese Academy of Sciences (Grant No. O5SY021107) and a preparatory project sponsored by the National Ministry of Science and Technology of China of the First Batch in the Basic Research Category of the National Program of Science & Technology in the Field of Countryside 2011-2015 (Preparatory Project No. NC2010CD0178).
Author information
Authors and Affiliations
Contributions
P.J., L.B. and D.Z. conceived and designed the experiments. X.C. performed the animal experiments. P.J., N.Z. and D.Z. analyzed the data. X.Z., D.L. and F.W. contributed reagents/materials/analysis tools. P.J. wrote the main manuscript text. All authors reviewed the manuscript.
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Electronic supplementary material
Supplementary Information
supplementary tables and figures
Rights and permissions
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder in order to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Jiang, P., Zhou, N., Chen, X. et al. Integrative analysis of differentially expressed microRNAs of pulmonary alveolar macrophages from piglets during H1N1 swine influenza A virus infection. Sci Rep 5, 8167 (2015). https://doi.org/10.1038/srep08167
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/srep08167
- Springer Nature Limited